Sanofi Winthrop Industrie SA

DUBLIN, Aug. 18, 2022 /PRNewswire/ -- The "Animal Health Active Pharmaceutical Ingredients Market Research Report by Business (Captive API and Merchant API), Indication, Synthesis, Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Animal Health Active Pharmaceutical Ingredients Market size was estimated at USD 14.92 billion in 2021, USD 16.11 billion in 2022, and is projected to grow at a CAGR 8.12% to reach USD 23.84 billion by 2027. Market Segmentation & Coverage: This research report categorizes the Animal Health Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Business, the market was studied across Captive API and Merchant API. Based on Indication, the market was studied across Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics. Based on Synthesis, the market was studied across Biotech and Synthetic. Based on Type, the market was studied across Branded and Generic. Based on End User, the market was studied across Pet Care Hospitals and Retail and specialty pharmacies. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Market Dynamics Drivers Rising adoption of pets across the globe Increasing awareness and expenditure among people regarding animal healthcare Significant growth in the number of animal healthcare NGOs Restraints Several risk factors associated with animal health APIs Opportunities Development of new products Unmet animal needs in many countries Challenges Limited awareness and availability in low-income areas Key Topics Covered: 1. Preface 2. Research Methodology 3. Executive Summary 4. Market Overview 5. Market Insights 6. Animal Health Active Pharmaceutical Ingredients Market, by Business 7. Animal Health Active Pharmaceutical Ingredients Market, by Indication 8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis 9. Animal Health Active Pharmaceutical Ingredients Market, by Type 10. Animal Health Active Pharmaceutical Ingredients Market, by End User 11. Americas Animal Health Active Pharmaceutical Ingredients Market 12. Asia-Pacific Animal Health Active Pharmaceutical Ingredients Market 13. Europe, Middle East & Africa Animal Health Active Pharmaceutical Ingredients Market 14. Competitive Landscape 15. Company Usability Profiles 16. Appendix Companies Mentioned Blanver Farmoquimica E Farmaceutica S.A. Changzhou Yabang-Qh Pharmachem Co., Ltd. Eli Lilly & Co. Excel Industries Ltd. Glenmark Pharmaceutical Ltd. Huvepharma Indukern, S.A. Lonza Group AG NGL Fine Chem Ltd. Ningxia Tairui Pharma CO. Ltd. Ofichem BV Omkar Speciality Chemicals Limited ouro fino saude animal P&R SpA (Olon SpA) Sanofi Winthrop Industrie (CEPiA) Sequent Scientific Ltd. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Shanghai Pharmtech Co. Ltd. Zhejiang Hisun Pharmaceutical Co. Ltd Zoetis Inc. For more information about this report visit Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

Pune, India, June 21, 2021 (GLOBE NEWSWIRE) -- Pharmaceutical Intermediates Market: Key InsightsAccording to our new research study on “Pharmaceutical Intermediates Market to 2028 – Global Analysis and Forecast – by Type, Application, Distribution Channel, and Geography,” the Pharmaceutical Intermediates Market Size is projected to reach US$ 37,290.33 million by 2028 from US$ 27,356.70 million in 2020; it is expected to grow at a CAGR of 4.2% during 2020–2028. Pharmaceutical Intermediates Market: Competition Landscape and Key DevelopmentsPfizer, Inc; Dishman Group; Dextra Laboratories Limited; Sanofi Winthrop Industries S.A; Vertellus Holdings LLC; BASF SE; Lianhetech; Codexis; Midas Pharma GmbH; and Chiracon GmbH are among the key companies operating in the pharmaceutical intermediates market. Leading players are focusing on the new product launch, expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities. In December 2019, Vertellus acquired Bercen Chemicals, a leading US-based supplier of alkyl succinic anhydrides and additives used in the fuel, lubricant, and paper industries. On the back of this acquisition, Vertellus is aiming to expand its offerings for the North American market, along with serving the global fuel and lubricant additives market more effectively. Get Exclusive Sample Pages of Pharmaceutical Intermediates Market - COVID-19 Impact and Global Analysis with Strategic Insights at In July 2019, BASF planned to invest in its second production plant for test-Butylamine (tBA) at BASF Specialty Chemicals Co. Ltd (BSNJ) in Nanjing, China. With this expansion, BASF’s global annual production capacity of tBA would increase by more than 30%. The plant is likely to resume operations in 2022 and would adopt advanced technologies of BASF to ensure the minimal generation of by-products in an advanced production process. BASF also operates tBA production plants in Antwerp, Belgium; and Geismar, Louisiana, US. In 2020, North America dominated the pharmaceutical intermediates market. The market growth in the region is credited to the factors such as increasing demand for pharmaceutical intermediates to produce APIs and growing support through initiatives to enhance pharmaceutical production, in addition to the factors driving the global market. Also, the growing pharmaceuticals industry in a Mexico is serving significant growth opportunities for the market players in the region. Based on type, the pharmaceutical intermediates market is segmented into GMP and non-GMP. The GMP segment held a larger share of the market in 2020 and is anticipated to register a higher CAGR in the market during the forecast period. The pharmaceutical intermediates market, by application, is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, whereas the vitamins segment is anticipated to register the highest CAGR during the forecast period. Based on distribution channel, the pharmaceutical intermediates market is segmented as distributors and direct sales. The direct sales segment held a larger share of the market in 2020, while the distributor segment is estimated to register a higher CAGR during 2020–2028. Download Sample PDF Brochure of Pharmaceutical Intermediates Market Growth Research Report at Pharmaceutical Intermediates Market: Segmental OverviewBased on type, the GMP segment held a larger share of the pharmaceutical intermediates market in 2020. Good Manufacturing Practices (GMP) are regulations by the US Food and Drug Administration that ensure that pharmaceutical products are consistently produced as per the defined quality standards. These regulations are designed to reduce the risks involved in the production of pharmaceuticals. Under the GMP guidelines, all aspects of manufacturing— from the raw materials, premises, and equipment to the training and personal hygiene of the staff—are covered. Detailed written procedures are crucial for each process that might affect the quality of the final product. The growing developments are likely to develop such systems that would offer documented proof that correct procedures are constantly followed at every step in the manufacturing process - every time the product is produced. The market for the GMP segment is expected to grow at the fastest CAGR during the forecast period owing to continuously ongoing developments in GMP. Increasing Adoption of AI-based Tools for Drug Discovery to be Future Trend in Pharmaceutical Intermediates Market:Artificial intelligence (AI) is emerging as important tool as it helps understand the action mechanism of drugs. The use of AI tools has already been proven to accelerate the process of discovering new therapeutic candidates; the process that earlier used to take years for completion can now be accomplished within months using the AI. in addition to reducing the timelines of drug discovery, AI also helps enhance the agility of the research process, increase the accuracy of predictions regarding drug efficacy and safety, and boost the speed and precision of discovery as well as preclinical testing, thereby enabling more competitive R&D strategies. Direct Purchase Copy of Pharmaceutical Intermediates Market Research Study at Many of pharmaceutical players are collaborating with AI companies for drug discovery. For instance, In June 2017, Genentech collaborated with GNS Healthcare to use the proprietary REFS casual machine learning and simulation AI platform of the later to identify and validate novel cancer drug targets. Similarly, GlaxoSmithKline (GSK) collaborated with Insilico Medicine, a Baltimore-based AI-driven company, to explore the AI capability of Insilico for easing the process of identification of novel biological targets. Browse Related Reports:Pharmaceutical Solvent Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Chemical Group (Alcohol, Amine, Esters, Ethers, Chlorinated Solvents, Others) - Molecular Cytogenetics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Consumables, Software and Services, Instruments, Kits and Reagents); Technology (Comparative Genomic Hybridization, Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Karyotyping, Others); Application (Oncology, Personalized Medicine, Genetic Disorders, Others); End User (Hospitals, Clinical and Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies) - About Us:The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Sameer JoshiE-mail: sales@theinsightpartners.comPhone: +1-646-491-9876 Press Release -

New York, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Pharmaceutical Intermediates Market By Type (GMP and Non-GMP), By Application (Antipyretic Analgesics, Vitamins, Antibiotics, and Others), By End-Users (Research Labs, Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026”. “According to the research study, the global Pharmaceutical Intermediates Market was estimated at USD 27515 Million in 2019 and is expected to reach USD 36209 Million by 2026. The global Pharmaceutical Intermediates Market is expected to grow at a compound annual growth rate (CAGR) of 4% from 2019 to 2027”. Pharmaceutical intermediates are present in active pharmaceutical ingredients that are used in making drugs for the treatment of diseases. The demands for these chemical components are surging owing to the increasing number of drug manufacturing companies across the globe. In addition to this, the transformation taking place in the pharmaceutical industry further helps expand the global Pharmaceutical Intermediates market. The demand for various ranges of drugs owing to the changing lifestyle in developing and developed regions is anticipated to propel the market. Request Your Free Sample Report of Pharmaceutical Intermediates Market @ (The free sample of this report is readily available on request). Our Free Sample Report Includes: • 2020 Updated Report Introduction, Overview, and In-depth industry analysis • 190+ Pages Research Report (Inclusion of Updated Research) • Provide Chapter-wise guidance on Request • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends • Includes Updated List of table & figures • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis • Facts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Offerings: Market Size & Forecast by Revenue | 2020−2027 Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography Competitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ (You may enquire a report quote OR available discount offers to our sales team before purchase.) Additionally, the various advancements taking place in the pharmaceutical organizations additionally help boom the development of pharmaceutical intermediates market size attain remedial goals. Apart from this, patent expiry is one of the major factors supporting the growth of the Pharmaceutical Intermediates market. The high expenditure on R&D activities and the need for appropriate treatment help enhance the Pharmaceutical Intermediates market growth over the forecast period. The growing geriatric population and incidences of chronic illness necessitate the demand for proper medication, thereby expanding the market of pharmaceutical intermediates. Top Market Players Some of the key market players of the global Pharmaceutical Intermediates market includes Easter Chemical Corporation, Aceto Corporation, Vertellus Holdings LLC, Lianhetech, BASF SE, Dishman Group, Cycle Pharma, Midas Pharma GmbH, A.R. Life Sciences Private Limited, Dextra Laboratories Ltd., Codexis, Inc., ZCL Chemicals Ltd., Chemcon Specialty Chemical Pvt. Ltd., and Sanofi Winthrop Industries S.A. To know an additional revised 2020 list of market players, request a sample report: The global Pharmaceutical Intermediates market research report delivers an acute valuation and taxonomy of the Pharmaceutical Intermediates industry by practically splitting the market on the basis of different types, applications, end-users, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. North America held the majority of the global Pharmaceutical Intermediates market share and is estimated to further expand during the forecast. The growth in North America attributes to the rising expenditure on drug development and discovery-related activities. Furthermore, the presence of top market players in the region helps surge the Pharmaceutical Intermediates market. The rapid development in the medical infrastructure has helped generate numerous opportunities for the market in the developing and developed regions. On the other hand, Asia Pacific is expected to exhibit the highest growth rate owing to the emerging pharmaceutical companies in countries like China and India. In addition, the growing number of geriatric populations and the prevalence of chronic diseases increase the demand for pharmaceutical intermediates. Browse the full “Pharmaceutical Intermediates Market By Type (GMP and Non-GMP), By Application (Antipyretic Analgesics, Vitamins, Antibiotics, and Others), By End-Users (Research Labs, Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at This report segments the global Pharmaceutical Intermediates market as follows: Global Pharmaceutical Intermediates Market: Type Segmentation Analysis GMP Non-GMP Global Pharmaceutical Intermediates Market: Application Segmentation Analysis Antipyretic Analgesics Vitamins Antibiotics Others Global Pharmaceutical Intermediates Market: End-Users Segmentation Analysis Research Labs Pharmaceutical Companies Contract Manufacturing Organizations Others Request Customized Copy of Report @ (We customize your report according to your research need. Ask our sales team for report customization.) Related Reports: Bladder Cancer Therapeutics Market: Pediatric And Adult Hemoconcentrators Market: Clinical Trials Market: Allergy Diagnostics Market: Hepatorenal Syndrome Treatment Market: About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: Follow Us Twitter: Contact Us: Facts & Factors USA: +1-347-989-3985 Email: sales@fnfresearch.com Web: